We are live on ! Find out more
VIM

Vinva Investment Management Portfolio holdings

AUM $8.07B
1-Year Est. Return 29.46%
This Fund
S&P 500
This Quarter Est. Return
+13.57%
1 Year Est. Return
+29.46%
3 Year Est. Return
+116.68%
5 Year Est. Return
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$397M
Cap. Flow
+$247M
Cap. Flow %
16.8%
Top 10 Hldgs %
29.27%
Holding
417
New
62
Increased
255
Reduced
73
Closed
27

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$17.2M
2
AAPL icon
Apple
AAPL
+$14.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$12.9M
4
MSFT icon
Microsoft
MSFT
+$10.9M
5
NVDA icon
NVIDIA
NVDA
+$7.67M

Sector Composition

Rank Sector Weight
1 Technology 31.76%
2 Financials 14.39%
3 Healthcare 12.74%
4 Consumer Discretionary 12.55%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
76
AT&T
T
$167B
$4.96M 0.34%
+296,583
New +$4.68M
PPG icon
77
PPG Industries
PPG
$25.7B
$4.96M 0.34%
32,995
+16,140
+96% +$2.18M
DBX icon
78
Dropbox
DBX
$7.49B
$4.96M 0.34%
166,848
+26,700
+19% +$741K
COP icon
79
ConocoPhillips
COP
$151B
$4.85M 0.33%
41,645
+6,312
+18% +$738K
AKAM icon
80
Akamai
AKAM
$16.8B
$4.78M 0.33%
40,202
-4,829
-11% -$537K
EBAY icon
81
eBay
EBAY
$47.7B
$4.29M 0.29%
98,647
+55,519
+129% +$2.3M
NOW icon
82
ServiceNow
NOW
$131B
$4.27M 0.29%
+30,415
New +$3.83M
ISRG icon
83
Intuitive Surgical
ISRG
$141B
$4.26M 0.29%
12,602
+1,709
+16% +$509K
GS icon
84
Goldman Sachs
GS
$302B
$4.25M 0.29%
11,005
+1,625
+17% +$542K
MCD icon
85
McDonald's
MCD
$193B
$4.23M 0.29%
14,284
+9,258
+184% +$2.52M
SYK icon
86
Stryker
SYK
$133B
$4.14M 0.28%
13,846
+3,727
+37% +$1.05M
BLK icon
87
Blackrock
BLK
$177B
$4.13M 0.28%
+5,069
New +$3.54M
BMY icon
88
Bristol-Myers Squibb
BMY
$130B
$4.08M 0.28%
79,675
+2,352
+3% +$123K
FERG icon
89
Ferguson
FERG
$49.1B
$3.94M 0.27%
20,408
+13,717
+205% +$2.31M
EXPE icon
90
Expedia Group
EXPE
$38.7B
$3.9M 0.27%
25,418
+1,456
+6% +$178K
ORCL icon
91
Oracle
ORCL
$417B
$3.88M 0.26%
36,541
-1,210
-3% -$132K
LRCX icon
92
Lam Research
LRCX
$388B
$3.88M 0.26%
49,130
+9,910
+25% +$675K
MDT icon
93
Medtronic
MDT
$115B
$3.84M 0.26%
46,384
+7,074
+18% +$539K
DKNG icon
94
DraftKings
DKNG
$12.5B
$3.8M 0.26%
105,147
+87,851
+508% +$2.94M
ELV icon
95
Elevance Health
ELV
$84.8B
$3.8M 0.26%
8,103
+1,099
+16% +$508K
C icon
96
Citigroup
C
$229B
$3.76M 0.26%
72,940
+16,452
+29% +$728K
RPM icon
97
RPM International
RPM
$14.9B
$3.75M 0.26%
33,435
+19,925
+147% +$2.01M
MSCI icon
98
MSCI
MSCI
$40.8B
$3.74M 0.25%
6,553
+2,617
+66% +$1.35M
NUE icon
99
Nucor
NUE
$62.3B
$3.71M 0.25%
21,194
-4,186
-16% -$664K
NTAP icon
100
NetApp
NTAP
$38.9B
$3.71M 0.25%
42,034
+34,008
+424% +$2.74M

Similar funds

Vinva Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Vinva Investment Management held 417 positions worth $1.47B, up 37% from $1.07B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Vinva Investment Management deployed $247M of net new capital in Q4 2023, opening 62 new positions and adding to 255 existing holdings. Its largest new stake was UnitedHealth: 32,283 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Idexx Laboratories, an estimated $4.19M trimmed.

  • Vinva Investment Management's largest Q4 2023 buy was UnitedHealth: 32,283 shares worth $16.9M.
  • Vinva Investment Management added most to Apple in Q4 2023, an estimated $14.3M increase.
  • Vinva Investment Management's biggest Q4 2023 reduction was Idexx Laboratories, cutting an estimated $4.19M.
  • Vinva Investment Management fully exited Clorox in Q4 2023, selling an estimated $3.43M.
  • Vinva Investment Management's ten largest holdings make up 29% of its $1.47B portfolio in Q4 2023.
  • Vinva Investment Management opened 62 new positions and closed 27 in Q4 2023.
  • Vinva Investment Management's portfolio value rose 37% quarter-over-quarter to $1.47B.

Based on Vinva Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.